- Home
- ZS vs WST Comparison
ZS vs WST Comparison
Compare ZS & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZS
- WST
- Stock Information
- Founded
- ZS 2007
- WST 1923
- Country
- ZS United States
- WST United States
- Employees
- ZS N/A
- WST N/A
- Industry
- ZS EDP Services
- WST Medical/Dental Instruments
- Sector
- ZS Technology
- WST Health Care
- Exchange
- ZS Nasdaq
- WST Nasdaq
- Market Cap
- ZS 31.7B
- WST 23.2B
- IPO Year
- ZS 2018
- WST N/A
- Fundamental
- Price
- ZS $187.26
- WST $332.77
- Analyst Decision
- ZS Buy
- WST Strong Buy
- Analyst Count
- ZS 35
- WST 5
- Target Price
- ZS $226.21
- WST $437.75
- AVG Volume (30 Days)
- ZS 2.5M
- WST 494.1K
- Earning Date
- ZS 12-02-2024
- WST 02-13-2025
- Dividend Yield
- ZS N/A
- WST 0.25%
- EPS Growth
- ZS N/A
- WST N/A
- EPS
- ZS N/A
- WST 6.74
- Revenue
- ZS $2,299,023,000.00
- WST $2,876,400,000.00
- Revenue This Year
- ZS $25.34
- WST N/A
- Revenue Next Year
- ZS $20.57
- WST $6.08
- P/E Ratio
- ZS N/A
- WST $49.37
- Revenue Growth
- ZS 30.77
- WST N/A
- 52 Week Low
- ZS $153.45
- WST $265.00
- 52 Week High
- ZS $259.61
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- ZS 41.23
- WST 58.00
- Support Level
- ZS $179.11
- WST $325.33
- Resistance Level
- ZS $209.39
- WST $335.53
- Average True Range (ATR)
- ZS 7.66
- WST 7.96
- MACD
- ZS -2.72
- WST 0.32
- Stochastic Oscillator
- ZS 21.68
- WST 78.28
About ZS Zscaler Inc.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.